Curis Shareholders Approve Major Equity and Charter Changes

The latest update is out from Curis ( (CRIS) ).

On March 17, 2026, Curis, Inc. held a virtual special meeting at which stockholders approved a new 2026 Incentive Plan, authorizing millions of additional shares for equity awards and allowing annual share pool increases through 2036, including up to 25,000,000 shares for incentive stock options. At the same meeting, investors backed a major increase in authorized capital and common shares and approved the issuance of stock underlying Series B preferred and multiple warrant series, moves that significantly expand Curis’s capacity to issue equity for financing, compensation and strategic purposes, with implications for future dilution and capital-raising flexibility.

Stockholders also approved a charter amendment raising authorized capital stock from 73,343,750 to 288,757,150 shares and authorized common stock from 68,343,750 to 283,757,150, effective upon filing in Delaware on March 17, 2026. Voting results showed strong, though not unanimous, support across proposals, positioning Curis with a much larger equity toolkit that may help fund operations and incentives but could alter ownership dynamics for existing shareholders.

The most recent analyst rating on (CRIS) stock is a Hold with a $0.89 price target. To see the full list of analyst forecasts on Curis stock, see the CRIS Stock Forecast page.

Spark’s Take on CRIS Stock

According to Spark, TipRanks’ AI Analyst, CRIS is a Neutral.

The score is held down primarily by weak financial durability (negative equity, higher debt, and continued cash burn) and bearish technicals (below key moving averages with negative MACD). Offsetting factors include constructive clinical/program updates and financing actions that may extend runway, but execution and funding/dilution risks remain central.

To see Spark’s full report on CRIS stock, click here.

More about Curis

Curis, Inc. is a publicly traded biopharmaceutical company, with its common stock listed on the Nasdaq Stock Market. The company’s capital structure includes common stock, convertible preferred stock and various series of warrants and pre-funded warrants, reflecting an active use of equity-linked securities in its financing and incentive arrangements.

Average Trading Volume: 512,318

Technical Sentiment Signal: Sell

Current Market Cap: $11.78M

Learn more about CRIS stock on TipRanks’ Stock Analysis page.